This inventor holds 1 USPTO granted patent and 4 published patent applications and 3 EPO patents. Top assignees: Dana-Farber-Cancer Institute Inc., Instituto Carlos Slim De La Salud, A.c., The Broad Institute, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Francisca Vazquez: Innovator in Cancer Treatment
Introduction
Francisca Vazquez is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of cancer treatment, particularly in addressing microsatellite unstable cancers. Her innovative work has led to the development of therapeutic methods that enhance the diagnosis and treatment of these challenging conditions.
Latest Patents
Francisca Vazquez holds a patent for her groundbreaking work titled "Therapeutic treatment of microsatellite unstable cancers." This patent focuses on compositions and methods for diagnosing and treating or preventing cancers characterized by microsatellite instability (MSI) and impaired mismatch repair (MMR). The disclosure emphasizes the identification of such cancers and the administration of inhibitors of the WRN helicase as therapeutic agents.
Career Highlights
Throughout her career, Francisca has worked with esteemed organizations, including the Broad Institute, Inc. and Instituto Carlos Slim de la Salud. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in cancer research.
Collaborations
Some of her notable coworkers include Adam Bass and Tsukasa Shibue. Their collaborative efforts have furthered the understanding and treatment of microsatellite unstable cancers.
Conclusion
Francisca Vazquez is a trailblazer in the field of cancer treatment, with her innovative patent addressing critical challenges in the diagnosis and management of microsatellite unstable cancers. Her contributions continue to impact the medical community and offer hope for improved therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile